Medicare AdvantageCoverageMedium impact
MA07.015a, Evaluation and Management (E&M) of Diabetic Peripheral Neuropathy with Loss of Protective Sensation (LOPS)
Independence Blue Cross·Endocrinology, Family Medicine, Internal Medicine +2 more·Medical Policy
Effective date
May 29, 2026
We identified it
Jun 19, 2026
Summary
Medicare Advantage policy MA07.015a regarding Evaluation and Management of Diabetic Peripheral Neuropathy with Loss of Protective Sensation has been archived. This indicates the policy is no longer active and may affect billing and coverage for diabetic neuropathy E&M services.
Action Required
By May 29, 2026: Billing team must verify current coverage criteria for diabetic peripheral neuropathy E&M services under Medicare Advantage plans. Contact payer to confirm replacement policy or updated guidelines. Review any pending claims for diabetic neuropathy management to ensure proper coding and coverage requirements.